Ufp Technologies (UFPT) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 312.00 |
| Dec 31, 2025 | 3,830.00 |
| Sep 30, 2025 | 506.00 |
| Jun 30, 2025 | 744.00 |
| Mar 31, 2025 | 389.00 |
| Dec 31, 2024 | -14.00 |
| Sep 30, 2024 | 257.00 |
| Jun 30, 2024 | 374.00 |
| Mar 31, 2024 | 450.00 |
| Dec 31, 2023 | 159.00 |
| Sep 30, 2023 | 226.00 |
| Jun 30, 2023 | 521.00 |
| Mar 31, 2023 | 666.00 |
| Dec 31, 2022 | -3,296.00 |
| Sep 30, 2022 | 1,888.00 |
| Jun 30, 2022 | 187.00 |
| Mar 31, 2022 | -18.00 |
| Dec 31, 2021 | 195.00 |
| Sep 30, 2021 | -106.00 |
| Jun 30, 2021 | 118.00 |
| Mar 31, 2021 | 592.00 |
| Dec 31, 2020 | -3,295.00 |
| Sep 30, 2020 | -33.00 |
| Jun 30, 2020 | -271.00 |
| Mar 31, 2020 | 232.00 |
| Dec 31, 2019 | 616.00 |
| Sep 30, 2019 | 307.00 |
| Jun 30, 2019 | 362.00 |
| Mar 31, 2019 | 94.00 |
| Dec 31, 2018 | -487.00 |
| Sep 30, 2018 | -103.00 |
| Jun 30, 2018 | -204.00 |
| Mar 31, 2018 | -314.00 |
| Dec 31, 2017 | -797.00 |
| Sep 30, 2017 | -554.00 |
| Jun 30, 2017 | -230.00 |
| Mar 31, 2017 | -276.00 |
| Dec 31, 2016 | -712.00 |
| Sep 30, 2016 | 44.00 |
| Jun 30, 2016 | -175.00 |
| Mar 31, 2016 | -745.00 |
| Dec 31, 2015 | -680.00 |
| Sep 30, 2015 | -347.00 |
| Jun 30, 2015 | -257.00 |